B-Raf specific antibody responses in melanoma patients

BMC Cancer
Joachim FensterleUlf R Rapp

Abstract

Mutations of the BRAF gene are the most common genetic alteration in melanoma. Moreover, BRAF mutations are already present in benign nevi. Being overexpressed and mutated, B-Raf is a potential target for the immune system and as this mutation seems to be an early event, a humoral immune response against this antigen might serve as a diagnostic tool for detection of high risk patients. 372 sera of 148 stage IV melanoma patients and 119 sera of non-melanoma patients were screened for B-Raf, B-Raf V599E and C-Raf specific antibodies by an ELISA assay. Sera were screened for specific total Ig and for IgG. Serum titers were compared with a two tailed Mann-Whitney U test. Sera with titers of 1:300 or higher were termed positive and groups were compared with a two tailed Fisher's exact test. B-Raf specific antibodies recognizing both B-Raf and B-Raf V599E were detected in 8.9% of the sera of melanoma patients and in 2,5% of the control group. Raf specific IgG was detected in some patients at very low levels. B-Raf specific antibody responses did not correlate with clinical parameters but in some cases, B-Raf antibodies emerged during disease progression. These findings imply that B-Raf is immunogenic in melanoma patients and that it ...Continue Reading

References

Aug 1, 1990·Journal of the American Academy of Dermatology·M A LecavalierN Gaid
Oct 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S S LeghaN Papadopoulos
May 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S S LeghaN Papadopoulos
Mar 4, 2000·International Journal of Cancer. Journal International Du Cancer·G RagupathiP O Livingston
Apr 17, 2001·Experimental Cell Research·K Ohman Forslund, K Nordqvist
Dec 18, 2001·International Journal of Cancer. Journal International Du Cancer·M H AndersenE Kämpgen
Mar 22, 2002·Nature Reviews. Cancer·P Carter
Mar 29, 2002·The Journal of Investigative Dermatology·Lars Østergaard PedersenJürgen C Becker
Apr 23, 2002·The British Journal of Dermatology·Thomas L Diepgen, V Mahler
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Nov 26, 2002·Immunological Reviews·Pierre G CoulieThierry Boon
Nov 26, 2002·Nature Genetics·Pamela M PollockPaul S Meltzer
Dec 31, 2002·International Journal of Clinical Pharmacology and Therapeutics·D StrumbergS Seeber
Jun 6, 2003·Oncogene·David Polsky, Carlos Cordon-Cardo
Jun 7, 2003·Advances in Enzyme Regulation·Ulf R RappRudolf Götz
Jun 10, 2003·International Journal of Cancer. Journal International Du Cancer·Peter MeyerClaus Garbe
Mar 5, 2004·Cancer Research·Melinda S SharkeySuzanne L Topalian
Mar 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Masaru ShinozakiDave S B Hoon
Aug 4, 2004·Cancer Research·Mads Hald AndersenJürgen C Becker
Feb 13, 2013·Clinical and Experimental Dermatology·G W M Millington

❮ Previous
Next ❯

Citations

May 24, 2006·Cancer Immunology, Immunotherapy : CII·Alfred ZippeliusDirk Jaeger
May 21, 2005·Archives of Dermatological Research·Claudia S VetterJürgen C Becker
Sep 17, 2010·The Journal of Biological Chemistry·Richard H WeisbartKeith Colburn
Mar 15, 2006·BMC Medicine·Joachim FensterleJürgen C Becker
Oct 20, 2010·Arthritis Research & Therapy·Caroline CharpinIsabelle Auger
Jan 15, 2011·Clinical & Developmental Immunology·Sebastian KoboldDjordje Atanackovic
Feb 22, 2012·Autoimmunity Reviews·Isabelle AugerJean Roudier
Feb 21, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jie WangJi Qiu
Aug 15, 2013·Brain Pathology·Avanita S PrabowoEleonora Aronica
Aug 9, 2006·International Journal of Cancer. Journal International Du Cancer·Ralf Schreck, Ulf R Rapp
Jan 28, 2016·Arthritis & Rheumatology·Fanny ArnouxIsabelle Auger
Sep 22, 2006·International Journal of Epidemiology·Paolo Vineis, Marianne Berwick
Feb 24, 2016·Scientific Reports·Andrea G MariaClaudio M Costa-Neto
Jul 15, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Andrei I ChapovalAlexander F Lazarev
Feb 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·F Stephen Hodi
Jun 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Taylor SittlerF Stephen Hodi
Mar 23, 2013·Molecular Immunology·Richard H WeisbartKeith Colburn

❮ Previous
Next ❯

Methods Mentioned

BETA
amino acid exchange
ELISA
electrophoresis

Software Mentioned

WESTERN Blot

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.